Late-onset frontotemporal dementia associated with progressive supranuclear palsy/argyrophilic grain disease/Alzheimer’s disease pathology
暂无分享,去创建一个
R. Petersen | B. Boeve | D. Knopman | D. Dickson | J. Parisi | D. Knopman | R. C. Petersen | M. Hutton | M. Baker | K. Josephs | K. Josephs | C. Jack | G. Rippon | M. Baker | G. Rippon | D. Dickson | R.I. Ivnik | R. I. Ivnik | D. Knopman | R. Ivnik
[1] M. Sjögren,et al. The prevalence of frontal variant frontotemporal dementia and the frontal lobe syndrome in a population based sample of 85 year olds , 2003, Journal of neurology, neurosurgery, and psychiatry.
[2] R. Petersen,et al. Progressive Nonfluent Aphasia and Subsequent Aphasic Dementia Associated with Atypical Progressive Supranuclear Palsy Pathology , 2003, European Neurology.
[3] P. Lantos,et al. Office of Rare Diseases Neuropathologic Criteria for Corticobasal Degeneration , 2002, Journal of neuropathology and experimental neurology.
[4] Dennis W. Dickson,et al. Ballooned neurons in progressive supranuclear palsy are usually due to concurrent argyrophilic grain disease , 2002, Acta Neuropathologica.
[5] J. Currie,et al. Frontal atrophy correlates with behavioural changes in progressive supranuclear palsy. , 2002, Brain : a journal of neurology.
[6] T. Iwatsubo,et al. Late‐onset frontotemporal dementia with a novel exon 1 (Arg5His) tau gene mutation , 2002, Annals of neurology.
[7] B Miller,et al. Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. , 2001, Archives of neurology.
[8] M. Rossor. Pick’s disease: A clinical overview , 2001, Neurology.
[9] E. Bigio,et al. Cortical Synapse Loss in Progressive Supranuclear Palsy , 2001, Journal of neuropathology and experimental neurology.
[10] E. Tolosa,et al. Familial atypical progressive supranuclear palsy associated with homozigosity for the delN296 mutation in the tau gene , 2001, Annals of neurology.
[11] M. Hutton,et al. Phenotypic correlations in FTDP-17 , 2001, Neurobiology of Aging.
[12] E. Kaplan,et al. The Boston naming test , 2001 .
[13] Hidenao Fukuyama,et al. Comparison of the pattern of atrophy of the corpus callosum in frontotemporal dementia, progressive supranuclear palsy, and Alzheimer's disease , 2000, Journal of neurology, neurosurgery, and psychiatry.
[14] C. Cotman,et al. Clinical and pathological evidence for a frontal variant of Alzheimer disease. , 1999, Archives of neurology.
[15] R. Faber,et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. , 1999, Neurology.
[16] D. F. Brown,et al. Progressive supranuclear palsy with dementia: cortical pathology. , 1999, Journal of neuropathology and experimental neurology.
[17] E. Tangalos,et al. Normative data for the Mattis Dementia Rating Scale. , 1998, Journal of clinical and experimental neuropsychology.
[18] Ronald C. Petersen,et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 , 1998, Nature.
[19] C. Jack,et al. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease , 1997, Neurology.
[20] D. Maraganore,et al. 2-30-01 Clinicopathologic heterogeneity in clinically- and/or pathologically-diagnosed cortical-basal ganglionic degeneration , 1997, Journal of the Neurological Sciences.
[21] A. Lang,et al. Cortical degeneration in progressive supranuclear palsy. A comparison with cortical-basal ganglionic degeneration. , 1997, Journal of neuropathology and experimental neurology.
[22] D. Dickson,et al. Neurodegenerative disorders with extensive tau pathology: A comparative study and review , 1996, Annals of neurology.
[23] I Litvan,et al. Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study. , 1996, Journal of neurology, neurosurgery, and psychiatry.
[24] J. Hodges,et al. Progressive supranuclear palsy presenting with dynamic aphasia. , 1996, Journal of neurology, neurosurgery, and psychiatry.
[25] M. Adams,et al. Complete analysis of the presenilin 1 gene in early onset Alzheimer's disease , 1996, Neuroreport.
[26] D. Dickson,et al. Neuropathologic Overlap of Progressive Supranuclear Palsy, Pick's Disease and Corticobasal Degeneration , 1996, Journal of neuropathology and experimental neurology.
[27] Y. Agid,et al. Are explicit memory disorders of progressive supranuclear palsy related to damage to striatofrontal circuits? Comparison with Alzheimer's, Parkinson's, and Huntington's diseases , 1994, Neurology.
[28] E G Tangalos,et al. Memory function in very early Alzheimer's disease , 1994, Neurology.
[29] D. Schaid,et al. Apolipoprotein E: risk factor for Alzheimer disease. , 1994, American journal of human genetics.
[30] P N Leigh,et al. Cognitive deficits in progressive supranuclear palsy, Parkinson's disease, and multiple system atrophy in tests sensitive to frontal lobe dysfunction. , 1994, Journal of neurology, neurosurgery, and psychiatry.
[31] F J Dunne,et al. Subcortical dementia. , 1993, BMJ.
[32] E. Tangalos,et al. The short test of mental status. Correlations with standardized psychometric testing. , 1991, Archives of neurology.
[33] Y Agid,et al. Positron emission tomography study in progressive supranuclear palsy. Brain hypometabolic pattern and clinicometabolic correlations. , 1990, Archives of neurology.
[34] J. Grafman,et al. Frontal lobe function in progressive supranuclear palsy. , 1990, Archives of neurology.
[35] A. Bol,et al. Positron tomography demonstrates frontal lobe hypometabolism in progressive supranuclear palsy , 1989, Annals of neurology.
[36] F Lhermitte,et al. Slowing of cognitive processing in progressive supranuclear palsy. A comparison with Parkinson's disease. , 1988, Archives of neurology.
[37] K P Offord,et al. A short test of mental status: description and preliminary results. , 1987, Mayo Clinic proceedings.
[38] A. Lees,et al. Cognitive deficits in the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). , 1985, Journal of neurology, neurosurgery, and psychiatry.
[39] S. Kish,et al. Progressive supranuclear palsy: Relationship between extrapyramidal disturbances, dementia, and brain neurotransmitter markers , 1985, Annals of neurology.
[40] M. Albert,et al. The `subcortical dementia' of progressive supranuclear palsy , 1974, Journal of neurology, neurosurgery, and psychiatry.
[41] J. Olszewski,et al. Progressive Supranuclear Palsy: A Heterogeneous Degeneration Involving the Brain Stem, Basal Ganglia and Cerebellum With Vertical Gaze and Pseudobulbar Palsy, Nuchal Dystonia and Dementia , 1964 .
[42] P. Rubé,et al. L’examen Clinique en Psychologie , 1959 .
[43] R. Reitan. Validity of the Trail Making Test as an Indicator of Organic Brain Damage , 1958 .
[44] L. Bender. A VISUAL MOTOR GESTALT TEST AND ITS CLINICAL USE , 1940 .
[45] Irene Litvan,et al. Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia , 2003, Annals of neurology.
[46] A. Rajput,et al. Progressive Supranuclear Palsy , 2001, Drugs & aging.
[47] E. Tangalos,et al. Neuropsychological tests' norms above age 55: COWAT, BNT, MAE token, WRAT-R reading, AMNART, STROOP, TMT, and JLO , 1996 .
[48] E. Tangalos,et al. Mayo's older americans normative studies: WAIS-R norms for ages 56 to 97 , 1992 .
[49] James F. Malec,et al. Mayo's older americans normative studies: Updated AVLT norms for ages 56 to 97 , 1992 .
[50] M. Tinker. A Visual Motor Gestalt Test and its Clinical Use. , 1940 .